High-precision surgical instruments and titanium alloy nails
PFNA (Proximal Femoral Nail Antirotation) systems have revolutionized the treatment of trochanteric fractures, particularly in an aging global population. As the prevalence of osteoporosis increases, the demand for stable, minimally invasive fixation methods has skyrocketed.
Historically, hip fractures were treated with Dynamic Hip Screws (DHS). However, the industrial shift toward intramedullary nailing—specifically the PFNA system—has been driven by superior biomechanical stability. The helical blade mechanism of the PFNA provides significantly better resistance to "cut-out" in osteoporotic bone compared to traditional lag screws. This clinical superiority has translated into a multi-billion dollar market globally, with major growth nodes in the Asia-Pacific, North America, and Europe.
International buyers, particularly from government hospitals and large private health groups, prioritize ISO 13485, CE, and FDA certifications. Supply chain stability and the ability to provide long-term follow-up clinical data are essential procurement criteria.
Localized application varies by region. For instance, the femoral anatomy of Asian populations often requires shorter nail options and modified curvature (ROC) compared to Caucasian demographics. As a leading manufacturer, we provide a full range of sizes.
Level-1 trauma centers require "Just-In-Time" (JIT) delivery. Our factory's large-scale production capacity ensures that distributors can maintain stock for emergency cases, including complex comminuted subtrochanteric fractures.
As a premier China PFNA System Manufacturer, we bridge the gap between high-end precision engineering and cost-effective medical solutions. The advantages of sourcing from our factory include:
We are dedicated to the research, development, production, and sales of orthopedic implants and tools. In the continuous process of design updates, we strive for excellence, meticulously crafting each product.
Our quality control philosophy: Quality and integrity first, striving for excellence, and pursuing the highest standards.
A professional R&D team and long-term technical exchanges with leading hospital experts ensure that our products function to their fullest potential.
Our factory has passed ISO 9001 and ISO 13485 certifications. Our products exceed all international quality and safety standards, including CE and FDA certifications. For many years, our products have been exported to more than 70 countries and regions in Europe, America, Africa, and Southeast Asia.
Our professional team is dedicated to serving every customer. Your trust is the greatest recognition of our service. We will rely on high-quality products and continuously launch new marketable products based on market demand, achieving mutual benefit and win-win results with our customers.
Expanding beyond PFNA to full trauma and joint replacement systems
The PFNA (Proximal Femoral Nail Antirotation) is an intramedullary nail system designed specifically for the treatment of proximal femoral fractures. Its primary innovation lies in the use of a helical blade instead of a standard lag screw. This blade compresses the bone tissue during insertion, rather than removing it, which is crucial for osteoporotic patients where bone density is low.
From a manufacturing perspective, the China PFNA manufacturer sector has adopted ultra-precision Swiss CNC machining to ensure that the tolerances between the helical blade and the nail's lateral hole are within microns. This minimizes "toggle" effects and enhances the mechanical "interlock" once the blade is deployed.
Technical Superiority in Modern Trauma: The PFNA system features a 6-degree lateral angle, which allows for insertion at the tip of the greater trochanter. This anatomical design minimizes the surgical trauma to the soft tissue and prevents further damage to the blood supply of the femoral head. Our titanium nails are also surface-treated with anodic oxidation to improve fatigue strength and biocompatibility.
Global procurement specialists often seek out China-based manufacturers like us because of our ability to produce OEM/ODM variations. Whether it is a modification in the proximal diameter or a specific variation in the distal locking configuration (static vs. dynamic), our manufacturing agility allows us to meet specific national clinical guidelines (e.g., DIN standards in Germany or GB standards in China).
In terms of clinical application, the PFNA system is indicated for peritrochanteric fractures, intertrochanteric fractures, and high subtrochanteric fractures. As surgeons move toward minimally invasive surgery (MIS), our PFNA instrument sets have been streamlined to include radiolucent carbon fiber aiming arms, allowing for clear X-ray visualization during the procedure.
The future of the PFNA system in the global market is tied to the concept of "personalized trauma care." We are currently exploring the integration of bioactive coatings such as hydroxyapatite (HA) to promote faster osseointegration at the blade-bone interface. This level of innovation confirms why China continues to be the preferred manufacturing hub for orthopedic systems worldwide.
Daher Orthopedic Implants
